"\"500\" Status: Internal Server Error" Starting to design clinical studies in India: Novartis
Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day' - By Asmita Patel

business

Starting to design clinical studies in India: Novartis

Global drug major Novartis has invested, expanded its research & development (R&D) capabilities in India. The global leader in biosimilars through its subsidiary Sandoz is assessing Indian market dynamics to launch its portfolio.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Sections